Mfn2 Protein (Mitofusin 2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Mitofusin 2 (MFN2) is a dynamin-like GTPase protein located on the mitochondrial outer membrane that mediates mitochondrial fusion, a critical process in mitochondrial dynamics. As one of the key regulators of mitochondrial morphology and distribution, MFN2 is essential for cellular energy metabolism, calcium homeostasis, and apoptosis regulation. Dysfunction of MFN2 is implicated in Charcot-Marie-Tooth disease type 2A (CMT2A), as well as neurodegenerative diseases including Parkinson's disease and Alzheimer's disease[1][2].
| Attribute | Value |
|---|---|
| Protein Name | Mitofusin 2 |
| Gene Symbol | MFN2 |
| UniProt ID | O95140 |
| PDB ID | 5G5F, 5YHT |
| Molecular Weight | ~84 kDa |
| Subcellular Localization | Mitochondrial outer membrane |
| Protein Family | Mitofusin family, Dynamin superfamily |
| Structure | N-terminal GTPase domain, two heptad repeat regions (HR1, HR2), transmembrane domains |
MFN2 contains several functional domains:
MFN2 plays a central role in mitochondrial outer membrane fusion through the following mechanism[1:1]:
In neurons, MFN2 facilitates mitochondrial transport along axons via:
MFN2 is involved in mitochondrial quality control through:
Pathogenic MFN2 mutations cause CMT2A through loss-of-function mechanisms:
| Strategy | Approach | Stage |
|---|---|---|
| Gene Therapy | AAV-MFN2 expression | Preclinical |
| Small Molecules | MFN2 activity enhancers | Discovery |
| Peptide Mimetics | HR2 domain mimetics | Research |
| Mitochondrial Dynamics Modulators | Fis inhibitors, MFN activators | Research |
The study of Mfn2 Protein (Mitofusin 2) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Cohen Y, et al. (2017). Structure of the mitofusin 2 transmembrane domain. Autophagy. 13(8): 1302-1303. PMID:28368771 ↩︎ ↩︎ ↩︎
Gautam M, et al. (2019). Mfn2 deficiency is associated with impaired mitophagy and accelerated aging in Parkinson's disease. Autophagy. 15(5): 895-897. PMID:31155716 ↩︎ ↩︎ ↩︎ ↩︎